[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100464148":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":52,"collaborators":24,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":24,"eligibilityCriteria":59,"healthyVolunteers":56,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":24,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":24,"overallStatus":38,"whyStopped":24,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"deep ESD group","EXPERIMENTAL","Performed according to the ESD standard procedure, the depth of dissection includes the SM3 layer (submucosa 1\u002F3 layer)",[13],"Procedure: ESD",{"label":15,"type":10,"description":16,"interventionNames":17},"shallow ESD group","Performed according to the ESD standard procedure, the depth of dissection does not include the SM3 layer (submucosa 1\u002F3 layer)",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"PROCEDURE","ESD","Endoscopic Submucosal Dissection for early gastric cancer",[9,15],null,[26],{"name":27,"affiliation":5,"role":28},"Xinliang Lu, professor","STUDY_DIRECTOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},"Yuqi Wang, Doctor","CONTACT","+86-15267019821","wyq@zju.edu.cn",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Second affiliated hospital, school of medicine, Zhejiang University","RECRUITING","Hangzhou","Zhejiang","310000","China","CN",{"type":45,"coordinates":46},"Point",[47,48],120.16142,30.29365,{"lat":48,"lon":47},[51],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},{"type":53,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100464148","the-relationship-between-scar-formation-and-esd-depth-in-therapy-for-gastric-carcinoma-100464148",false,"NCT05323929","The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma","Inclusion Criteria:\n\n* Patients older than 18 years old and younger than 75 years old.\n* Early gastric cancer (T1a stage) diagnosed by gastroscopy or ultrasonography, differentiated and no ulcer; or early gastric cancer (T1a stage), differentiated with ulcer, lesion diameter \\\u003C3cm; or early gastric cancer (T1a stage), undifferentiated and No ulcer, lesion diameter \\\u003C2cm.\n* Pathological diagnosis of gastric cancer.\n* No further treatment is required.\n* Patients diagnosed for the first time without other serious gastrointestinal diseases.\n\nExclusion Criteria:\n\n* Those who did not comply with the test requirements, obviously violated this protocol, or switched to other protocols in the middle of treatment.\n* Advanced gastric cancer; or undifferentiated gastric cancer lesions \\> 2 cm in diameter; or differentiated gastric cancer with ulcer lesions \\> 3 cm in diameter.\n* Coagulation disorders.\n* Serious heart, liver, kidney and other diseases, can not tolerate ESD treatment.\n* Patients with gastric cancer complications such as gastrointestinal bleeding and perforation that need emergency treatment.\n* Patients with distant metastasis.\n* Patients with other tumors, patients with a history of malignant tumors (except early carcinoma in situ.\n* The patient himself requests to withdraw from the trial.\n* The researcher believes that the patient is not suitable to participate in this study.","ALL","18 Years","75 Years",{"count":64,"type":65},200,"ESTIMATED","INTERVENTIONAL",[68],"NA","This study is a single-center, prospective, group-controlled clinical trial, aiming to clarify the relationship between the depth of dissection and scar formation in the treatment of early gastric cancer by ESD, and to provide high-quality evidence-based medicine for the treatment of early gastric cancer.",[71,72],"Early Gastric Cancer","Endoscopic Submucosal Dissection","2022-04-12",{"date":75,"type":76},"2022-04-14","ACTUAL",{"date":78,"type":76},"2022-01-01",{"date":80,"type":65},"2027-12-31",{"name":5,"class":6},1]